CPNE3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.748600E-01
Normal-vs-Stage2
7.526600E-01
Normal-vs-Stage3
2.994400E-01
Normal-vs-Stage4
6.880400E-01
Stage1-vs-Stage2
8.343400E-01
Stage1-vs-Stage3
3.412600E-01
Stage1-vs-Stage4
5.220000E-01
Stage2-vs-Stage3
3.509400E-01
Stage2-vs-Stage4
2.370400E-01
Stage3-vs-Stage4
2.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.198000E-01
Normal-vs-AfricanAmerican
8.766800E-01
Normal-vs-Asian
4.312200E-01
Caucasian-vs-AfricanAmerican
5.748200E-01
Caucasian-vs-Asian
3.837600E-01
AfricanAmerican-vs-Asian
2.666600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.352400E-01
Normal-vs-Female
8.465800E-01
Male-vs-Female
8.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.074000E-01
Normal-vs-Age(41-60Yrs)
8.722000E-01
Normal-vs-Age(61-80Yrs)
7.550800E-01
Normal-vs-Age(81-100Yrs)
6.132400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.716830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.880600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.879600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.721700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.474400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.027400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.294800E-01
Normal-vs-Daily Drinker
6.583800E-01
Normal-vs-Weekly Drinker
4.829400E-01
Normal-vs-Occasional Drinker
8.430400E-01
Normal-vs-Social Drinker
8.955000E-01
Non Drinker-vs-Daily Drinker
9.096600E-01
Non Drinker-vs-Weekly Drinker
8.437800E-01
Non Drinker-vs-Occasional Drinker
1.176030E-01
Non Drinker-vs-Social Drinker
4.463000E-01
Daily Drinker-vs-Weekly Drinker
8.044200E-01
Daily Drinker-vs-Occasional Drinker
2.298200E-01
Daily Drinker-vs-Social Drinker
5.896200E-01
Weekly Drinker-vs-Occasional Drinker
1.619560E-01
Weekly Drinker-vs-Social Drinker
4.472600E-01
Occasional Drinker-vs-Social Drinker
5.693200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.535850E-01
Normal-vs-Grade 2
1.053760E-02
Normal-vs-Grade 3
3.444000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.685000E-01
Grade 1-vs-Grade 3
8.300000E-01
Grade 1-vs-Grade 4
1.535850E-01
Grade 2-vs-Grade 3
5.150800E-01
Grade 2-vs-Grade 4
1.053760E-02
Grade 3-vs-Grade 4
3.444000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.888400E-01
Normal-vs-NonDiabetic
7.688000E-01
Diabetic-vs-NonDiabetic
5.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.562200E-01
Normal-vs-NoPancreatitis
8.066200E-01
Pancreatitis-vs-NoPancreatitis
4.474800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.419400E-01
Normal-vs-N1
7.906000E-01
N0-vs-N1
6.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.274400E-01
Normal-vs-TP53-NonMutant
9.761400E-01
TP53-Mutant-vs-TP53-NonMutant
2.138600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
